Facultad de Ciencias de la Salud
Facultad
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (46)
2023
-
Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms
Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922
-
Automatic antibiotic resistance prediction in Klebsiella pneumoniae based on MALDI-TOF mass spectra
Engineering Applications of Artificial Intelligence, Vol. 118
-
Thiosulfinate-Enriched Allium sativum Extract Exhibits Differential Effects between Healthy and Sepsis Patients: The Implication of HIF-1α
International journal of molecular sciences, Vol. 24, Núm. 7
2022
-
The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives
Microorganisms, Vol. 10, Núm. 4
2021
-
SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown
Scientific Reports, Vol. 11, Núm. 1
2020
-
Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella
Medical Mycology, Vol. 58, Núm. 1, pp. 83-92
-
Corrigendum to ‘Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect’ [Clinical Microbiology and Infection, Volume 24, (Issue 12) (December 2018) Pages 1343.e1-1343.e4](S1198743X18305214)(10.1016/j.cmi.2018.07.006)
Clinical Microbiology and Infection
-
Corrigendum to “Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect” [Clin Microbiol Infect 24 (12) (December 2018) 1343.e1-1343.e4](10.1016/j.cmi.2018.07.006)
Clinical Microbiology and Infection
-
Erratum: Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect (Clinical Microbiology and Infection (2018) 24(12) (1343.e1–1343.e4), (S1198743X18305214), (10.1016/j.cmi.2018.07.006))
Clinical Microbiology and Infection
-
Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial
Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162
2019
-
Does the composition of polystyrene trays affect candida spp. biofilm formation?
Medical Mycology, Vol. 57, Núm. 4, pp. 504-509
-
Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 3, pp. 607-614
-
Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis
Journal of Cystic Fibrosis, Vol. 18, Núm. 5, pp. 630-635
2018
-
Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years
Journal of Antimicrobial Chemotherapy
-
Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect
Clinical Microbiology and Infection, Vol. 24, Núm. 12, pp. 1343.e1-1343.e4
-
Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata
Medical Mycology, Vol. 56, Núm. 7, pp. 903-906
-
Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method
Clinical Microbiology and Infection, Vol. 24, Núm. 11, pp. 1200-1204
-
Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical candida glabrata isolates
Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 3
-
Resistance to echinocandins in candida can be detected by performing the etest directly on blood culture samples
Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 6
2017
-
Antibiotic prescription patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
Farmacia Hospitalaria, Vol. 41, Núm. 3, pp. 391-400